HTXD: Treatment: ARV Drugs |
$454,045,332 |
HLAB: Laboratory Infrastructure |
$110,996,236 |
OHSS: Health Systems Strengthening |
$108,267,197 |
HTXS: Treatment: Adult Treatment |
$107,167,935 |
HKID: Care: Orphans and Vulnerable Children |
$89,317,175 |
HVCT: Testing: HIV Testing and Counseling |
$72,298,634 |
HBHC: Care: Adult Care and Support |
$71,443,768 |
HVSI: Strategic Information |
$56,329,680 |
HVAB: Sexual Prevention: Abstinence/Be Faithful |
$43,325,820 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission |
$42,609,959 |
HVOP: Sexual Prevention: Other Sexual Prevention |
$40,589,297 |
HMIN: Biomedical Prevention: Injection Safety |
$37,830,761 |
HVTB: Care: TB/HIV |
$31,706,851 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision |
$28,600,981 |
HMBL: Biomedical Prevention: Blood Safety |
$8,385,950 |
PDTX: Treatment: Pediatric Treatment |
$6,594,540 |
PDCS: Care: Pediatric Care and Support |
$3,350,318 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use |
$3,156,402 |
HVMS: Management and Operations |
$1,549,744 |